

Fractyl Health (GUTS) stock sank 50% despite positive REMAIN-1 trial results as class action lawsuit concerns weigh on investors.
You can purchase shares of Fractyl Health (NASDAQ:GUTS) through any online brokerage.
Other companies in Fractyl Health’s space includes: Abbott Laboratories (NYSE:ABT), Intuitive Surgical Inc (NASDAQ:ISRG), Medtronic PLC (NYSE:MDT), Stryker Corp (NYSE:SYK) and Boston Scientific Corp (NYSE:BSX).
Fractyl Health has a consensus price target of $62.37.
The stock price for Fractyl Health (NASDAQ: GUTS) is $1.06 last updated October 23, 2026 at 7:50 PM EDT.
There are no upcoming dividends for Fractyl Health.
Fractyl Health does not have any upcoming earnings scheduled.
There is no upcoming split for Fractyl Health.
Fractyl Health is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.
Fractyl Health Inc is a clinical stage metabolic therapeutics company focused on pioneering novel approaches to treat obesity and type 2 diabetes (T2D). Its Revita and Rejuva candidates are designed to target root causes of metabolic diseases,...